Your browser doesn't support javascript.
loading
Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis.
Zhou, Sirui; Sosina, Olukayode A; Bovijn, Jonas; Laurent, Laetitia; Sharma, Vasundhara; Akbari, Parsa; Forgetta, Vincenzo; Jiang, Lai; Kosmicki, Jack A; Banerjee, Nilanjana; Morris, John A; Oerton, Erin; Jones, Marcus; LeBlanc, Michelle G; Idone, Vincent; Overton, John D; Reid, Jeffrey G; Cantor, Michael; Abecasis, Goncalo R; Goltzman, David; Greenwood, Celia M T; Langenberg, Claudia; Baras, Aris; Economides, Aris N; Ferreira, Manuel A R; Hatsell, Sarah; Ohlsson, Claes; Richards, J Brent; Lotta, Luca A.
Afiliación
  • Zhou S; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Sosina OA; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada.
  • Bovijn J; Department of Human Genetics, McGill University, Montréal, Quebec, Canada.
  • Laurent L; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Sharma V; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Akbari P; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Forgetta V; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Jiang L; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Kosmicki JA; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Banerjee N; Five Prime Sciences Inc, Montréal, Québec, Canada.
  • Morris JA; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Oerton E; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Jones M; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • LeBlanc MG; New York Genome Center, New York, NY, USA.
  • Idone V; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Overton JD; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Cantor M; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Abecasis GR; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Goltzman D; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Greenwood CMT; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Langenberg C; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Baras A; Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
  • Economides AN; Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Quebec, Canada.
  • Ferreira MAR; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada.
  • Hatsell S; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada.
  • Ohlsson C; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
  • Richards JB; Computational Medicine, Berlin Institute of Health, Charité University Medicine Berlin, Berlin, Germany.
  • Lotta LA; Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
Nat Genet ; 55(8): 1277-1287, 2023 08.
Article en En | MEDLINE | ID: mdl-37558884
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Predisposición Genética a la Enfermedad Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Predisposición Genética a la Enfermedad Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Canadá